44 results
Page 2 of 3
8-K
EX-99.1
r7hvstsjw0y 9vpa
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.2
jw1tx6kd4c d6b9
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
hyroh2b4977z i3
17 Feb 22
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
4:03pm
8-K
EX-99.1
p0s37z24
9 Nov 21
Ligand Reports Third Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
xmg4jglgid9fo
29 Jul 21
Ligand Reports Second Quarter 2021 Financial Results
4:04pm
8-K
EX-99.1
1dbol4rq
3 May 21
Ligand Reports First Quarter 2021 Financial Results
4:11pm
8-K
EX-99.1
3mjkm1b8wedt
3 Feb 21
Ligand Reports Fourth Quarter and Full Year 2020 Financial Results
7:45am
8-K
EX-99.1
f5fxj2tk1 m5
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K
EX-99.1
hk1g uihs0kvz
30 Oct 20
Ligand Reports Third Quarter 2020 Financial Results
8:03am
8-K
EX-99.1
qrq 1oljnu98i6h230i
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-2.1
9jpuf6woghk
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-10.1
vp1vzznqdffswwatt
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm